1. Zavalishin, I.A. and Zakharova, M.N., Multiple sclerosis: results and perspectives of the study, Zh. Nevropatol. Psikhiatr. im. S.S. Korsakova, 1982, vol. 82, no. 2, pp. 161–167.
2. Zavalishin, I.A., Zakharova, M.N., Zhuchenko, T.D., and Peresedova, A.V., Etiology and pathogenesis of multiple sclerosis, in Rasseyannyi skleros. Izbrannye voprosy teorii i praktiki (Multiple Sclerosis: Selected Issues of Theory and Practice), Zavalishin, I.A. and Golovkin, V.I., Eds., Moscow: Issled. Tsentr Nevrol., Ross. Akad. Med. Nauk, 2000, pp. 537–579.
3. Bisaga, G.N., Kovalenko, A.V., Isayeva, G.E., et al., The use of mesenchymal stem cells in optic atrophy in patients with multiple sclerosis: a pilot study, Ann. Klin. Eksp. Nevrol., 2017, vol. 11, no. 2, pp. 26–31.
4. Ryabtseva, M.S., Negudova, N.P., Batuashvili, T.A., and Simutenko, L.V., Experimental evaluation of bioequivalence of original and reproduced peptide preparations in multiple sclerosis, Ann. Klin. Eksp. Nevrol., 2018, vol. 12, no. 2, pp. 39–44.
5. Votintseva, M.V., Petrov, A.M., and Stolyarov, I.D., Drugs based on monoclonal antibodies: The present and the future in the treatment of multiple sclerosis (based on the materials of the 32nd Congress of the European Committee for the Treatment and Research of Multiple Sclerosis–ECTRIMS), Ann. Klin. Eksp. Nevrol., 2017, vol. 11, no. 2, pp. 83–88.